Skip to main content
Signal8
Groupe Bruxelles Lambert logo

Groupe Bruxelles Lambert

CIK: 1179313

Last 13F

Aug 7, 2026

Next 13F

Nov 16, 2026 · in 7 days

13F Portfolio Value

$62.16M

Not total AUM

New Positions

0

Increased

0

Exit Positions

0

Holdings (1)

Q2 2026 13F, quarter ended Jun 30, 2026, filed Aug 6, 2026

  • CONCENTRIX CORP logo
    CNXC

    CONCENTRIX CORP

    $62.16M

    2.77M sh100.00%-68.4%

1-1 of 1

Sector Allocation

SEC Filings

FormDescriptionFiled

About Groupe Bruxelles Lambert

Groupe Bruxelles Lambert is an Investment Adviser that reports its US-listed stock and option positions to the SEC on Form 13F (CIK 1179313). Signal8 holds 17 13F filings from it.

Its most recent 13F holdings report covers Q2 2026 (the quarter ended Jun 30, 2026) and was filed on Aug 6, 2026. That report lists 1 security, not counting options, the same number as in Q1 2026.

Its largest reported position is CONCENTRIX CORP (CNXC).

Recent 13F filings by Groupe Bruxelles Lambert

  • Q2 2026: 13F-HR filed Aug 6, 2026, listing 1 security.
  • Q1 2026: 13F-HR filed May 6, 2026, listing 1 security.
  • Q4 2025: 13F-HR filed Feb 4, 2026, listing 1 security.
  • Q3 2025: 13F-HR filed Dec 18, 2025, listing 1 security.
  • Q2 2025: 13F-HR filed Jul 30, 2025, listing 1 security.
  • Q1 2025: 13F-HR filed May 10, 2025, listing 1 security.

What a Form 13F does and does not show